Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 6, 2008, Pages 751-757

  Bork, K ^a   Staubach, P ^a   Hardt, J ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Angio oedema; C1 inhibitor deficiency; Hereditary angio oedema; Pasteurized C1 inhibitor concentrate; Skin swellings

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; PAIN; PRIORITY JOURNAL; SKIN SWELLING; TENSION; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANGIOEDEMA, HEREDITARY; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SKIN;

EID: 42549110137     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01577.x     Document Type: Article

References (33)

1. Quincke HI. Über akutes umschriebenes Hautödem. Monatsh Prakt Dermatol 1882 1 : 129 131.
2. Osler W. Hereditary angioneurotic edema. Am J Med Sci 1888 95 : 362 367.
3. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C1-esterase. Am J Med 1963 31 : 37 44.
4. Rosen FS, Pensky J, Donaldson V, Charache P. Hereditary angioedema: two genetic variants. Science 1965 148 : 957 958.
5. Zuraw BL, Herschbach J. Detection of C1 inhibitor mutations in patients with hereditary angioedema. J Allergy Clin Immunol 2000 105 : 541 546.
6. Bowen B, Hawk JJ, Sibunka S, Hovicks S, Weiler JM. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. Clin Immunol 2002 98 : 157 163.
7. Kalmar L, Bors A, Farkas H, Vas S, Fandl B, Varga L et al. Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema. Hum Mutat 2003 22 : 498.
8. Cugno M, Cicardi M, Bottasso B, Coppola R, Paonessa R, Mannucci PM et al. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood 1997 89 : 3213 3218.
9. Arlaud GJ, Rossi V, Thielens NM, Gaboriaud C, Bersch B, Hernandez JF. Structural and functional studies on C1r and C1s: new insights into the mechanisms involved in C1 activity and assembly. Immunobiology 1998 199 : 303 316.
10. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998 351 : 1693 1697.
11. Bork K, Barnstedt S, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000 356 : 213 217.
12. Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 2006 343 : 1286 1289.
13. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin N Am 2006 26 : 709 724.
14. Brackertz D, Kueppers F. Hereditary angioneurotic oedema. Lancet 1973 2 : 680.
15. Gadek JE, Hosea SW, Gelfand JA, Sautaella M, Wickerhauser M, Triantaphyllopoulos DC et al. Replacement therapy in hereditary angioedema. Successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N Engl J Med 1980 302 : 542 546.
16. Waytes T, Rosen FS, Frank M. Treatment of hereditary angioedema with a vapor-heated C1 INH. N Engl J Med 1996 334 : 1630 1634.
17. Kunschak M, Engl W, Maritsch F, Rosen FS, Eder G, Zerlauth G et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998 38 : 540 549.
18. Visentin DE, Yang WH, Karsh J. C1-esterase inhibitor transfusions in patients with hereditary angioedema. Ann Allergy Asthma Immunol 1998 80 : 457 461.
19. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 2001 161 : 714 718.
20. Bork K, Meng G, Staubach P, Hardt J. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 2005 45 : 1774 1784.
21. Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 2006 117 : 904 908. Epub. 2006 Feb. 14.
22. Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W, Zingale L et al. Canadian 2003 International Consensus Algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 2004 114 : 629 637.
23. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006 119 : 267 274.
24. Bork K, Hardt J, Schicketanz K-H, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 2003 163 : 1229 1235.
25. StataCorp. Stata Statistical Software V9.2, College Station, TX : Stata Corporation, 2005.
26. Cicardi M, Bergamaschini L, Marasini B, Boccassini G, Tucci A, Agostoni A. Hereditary angioedema: an appraisal of 104 cases. Am J Med Sci 1982 284 : 2 9.
27. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992 71 : 206 215.
28. Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 2000 75 : 349 354.
29. Bork K, Barnstedt SE. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc 2003 134 : 1088 1094.
30. Cicardi M, Zingale L. How do we treat patients with hereditary angioedema? Transfusion Apheresis Sci 2003 29 : 221 227.
31. Cicardi M, Mannucci PM, Castelli R, Rumi MG, Agostoni A. Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate. Transfusion 1995 35 : 209 212.
32. Juers M, Gröner A. Virus safety of currenty plasma-derived C1-INH: the Aventis Behring experience. J Allergy Clin Immunol 2004 114 (Suppl. 3 S96 S98.
33. Rothwell PM. External validity of randomised controlled trials: to whom do the results of this trial apply? Lancet 2005 365 : 82 93.